IN8bio to Present New Preclinical Data on Novel Gamma-Delta (γδ) T cell Engager Platform for Cancer Immunotherapy at AACR Annual Meeting 2025
IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies ...
News Medical on MSN13d
Abnormal Immune Cell Function May Lead to Crohn’s Disease
A research team has uncovered abnormal immune cell function mechanisms that may lead to Crohn’s disease. Their discovery ...
News Medical on MSN11d
High-Salt Diet Linked to Depression-like Symptoms
The researchers also identified a type of immune cell called gamma-delta T cells (γδT cells) as an important source of IL-17A ...
Researchers find mechanisms that may lead to IBD
A team of scientists has discovered mechanisms of abnormal immune cell function that may lead to Crohn’s disease, an ...
Analysts Set Adicet Bio, Inc. (NASDAQ:ACET) Price Target at $7.50
Shares of Adicet Bio, Inc. (NASDAQ:ACET – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the ...
Business Insider6d
IN8bio to Present New Preclinical Data on Novel Gamma-Delta (γδ) T cell Engager Platform for Cancer Immunotherapy at AACR Annual Meeting 2025
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune ...
In8bio To Present New Preclinical Data On Novel Gamma-Delta (Γδ) T Cell Engager Platform For Cancer Immunotherapy At AACR Annual Meeting 2025
Poster Title: A novel gamma-delta T cell engager platform for cancer immunotherapy Session Title: Immunology/T Cell Engagers and Novel Antibody-Based Therapies Session Date and Time: Wednesday, April ...